Q3 2023 Holdings
Filed 2023-11-14 | 81 holdings | $355.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $22.3M | 1,045,110 | 6.3% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $20.4M | 2,000,000 | 5.7% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $16.8M | 1,129,376 | 4.7% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $16.4M | $17,000,000 | 4.6% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $15.0M | 685,061 | 4.2% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $14.4M | 400,000 | 4.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $13.4M | 450,000 | 3.8% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $12.4M | 85,000 | 3.5% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $11.7M | 239,108 | 3.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $11.5M | 300,000 | 3.2% |
| Teva Pharmaceutical Inds LTD(TEVA)Call | SPONSORED ADS | 881624209 | $11.2M | 1,100,000 | 3.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $10.3M | 300,438 | 2.9% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $7.8M | 856,535 | 2.2% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $7.5M | 1,000,300 | 2.1% |
| ARK ETF TR(ARKG)Put | GENOMIC REV ETF | 00214Q302 | $7.0M | 250,000 | 2.0% |
| Establishment Labs Hldgs Inc(ESTA)Call | COM | G31249108 | $6.9M | 140,000 | 1.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $6.8M | 230,366 | 1.9% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $6.7M | 57,500 | 1.9% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $6.6M | 1,018,091 | 1.9% |
| Morphic Hldg Inc | COM | 61775R105 | $6.2M | 270,000 | 1.7% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $6.0M | 368,329 | 1.7% |
| Inozyme Pharma Inc | COM | 45790W108 | $5.8M | 1,379,852 | 1.6% |
| Alkermes PLC(ALKS)Call | SHS | G01767105 | $5.6M | 200,000 | 1.6% |
| Apellis Pharmaceuticals Inc(APLS)Put | COM | 03753U106 | $4.9M | 130,000 | 1.4% |
| Immunovant Inc(IMVT)Put | COM | 45258J102 | $4.9M | 128,100 | 1.4% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $4.6M | 1,992,466 | 1.3% |
| Savara Inc(SVRA) | COM | 805111101 | $4.3M | 1,150,000 | 1.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $4.3M | 46,400 | 1.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $4.1M | 150,000 | 1.2% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $4.1M | 60,000 | 1.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $3.9M | 350,000 | 1.1% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $3.8M | 79,214 | 1.1% |
| Viking Therapeutics Inc(VKTX)Put | COM | 92686J106 | $3.7M | 332,600 | 1.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $3.6M | 2,850,000 | 1.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $3.3M | 300,000 | 0.9% |
| Aeglea Biotherapeutics Inc(SYRE) | COM NEW | 00773J202 | $3.0M | 242,297 | 0.8% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $3.0M | 200,000 | 0.8% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $2.9M | 50,000 | 0.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $2.8M | 100,000 | 0.8% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $2.7M | 278,292 | 0.8% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $2.6M | 60,426 | 0.7% |
| Immatics N.v(IMTX) | SHS | N44445109 | $2.3M | 200,000 | 0.7% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $2.3M | 50,000 | 0.6% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $2.1M | 10,000 | 0.6% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $2.1M | 30,000 | 0.6% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $2.0M | 250,000 | 0.6% |
| Aclaris Therapeutics Inc(ACRS)Put | COM | 00461U105 | $1.8M | 260,000 | 0.5% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $1.8M | 150,000 | 0.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $1.6M | 325,000 | 0.5% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $1.5M | 40,000 | 0.4% |